The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures

Zeynal Karaca; Steven N. Wiggins

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Methodology and Healthcare Policy

Vol. 1, Issue 3, 2014

February 26, 2016 EDT

The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures

Zeynal Karaca, Steven N. Wiggins,

mepsprescription drugshealthcare expendituresdrug classes

ccby-4.0

Photo by Haley Lawrence on Unsplash

JHEOR

Karaca Z, Wiggins SN. The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures. JHEOR. 2016;1(3):276-295.